Brilliant technology: by the end of July, it had bought back 4.88% of its shares

IntoCare Zhang Hui: Ingenuity Forges Quality, Continuous Improvement Safeguards Lives

In 2024, nearly all medical enterprises are exploring overseas markets. This trend is driven by an anti-corruption wave within the medical industry, the demand for financing and initial public offerings, as well as challenges such as excess production capacity. Presently, venturing abroad has become an essential developmental path for medical device enterprises. Successfully entering foreign markets is not only a crucial means for the medical industry to achieve a second grow

Zhongan Online Sees a Loss of 750 Mn in H1 2022 though with an Increased Revenue

ZhongAn Online suffered a decrease in profit but an increase in revenue in H1 2022.

Amid the Digitalization Boom: ZhongAn is Speeding Up

ZhongAn starts to show its forte in the race over online insurance.

As Crackdown Looms, Chinese Insurtech Waterdrop Enters Next Growth Phase

The company's widening losses come along with the user base expansion.

China's Fintech: 6 Listed Firms Giving Access to Asia's Most Vibrant Ecosystem

Together with Tellimer – a global technology, information, and data provider with over 20 years' experience in financial markets – we highlight six innovative players operating across a broad swathe of the fintech landscape.